Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries
Jonathan S. Nguyen‐Van‐Tam, Maureen A. O’Leary, Emily T. Martin, et al.
European Respiratory Review (2022) Vol. 31, Iss. 166, pp. 220105-220105
Open Access | Times Cited: 115

Showing 51-75 of 115 citing articles:

Sex differences in acute respiratory tract infections—multi-year analysis based on data from a large tertiary care medical center in Israel
Victoria Peer, Michal Mandelboim, Menucha Jurkowicz, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Respiratory Viruses and Virus-like Particle Vaccine Development: How Far Have We Advanced?
Ki‐Back Chu, Fu‐Shi Quan
Viruses (2023) Vol. 15, Iss. 2, pp. 392-392
Open Access | Times Cited: 11
Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7–8, 2022
Meagan C. Fitzpatrick, Rachel S. Laufer, Ranju Baral, et al.
Vaccine (2023) Vol. 41, Iss. 48, pp. 7047-7059
Open Access | Times Cited: 11
A Randomized, Double‐Blind, Placebo‐Controlled, Phase 1 Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Single Vaccination of Ad26.RSV.preF‐Based Regimen in Japanese Adults Aged 60 Years and Older
Takashi Eto, Yusuke Okubo, Atsushi Momose, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 6
Open Access | Times Cited: 3
Burden of Respiratory Syncytial Virus–Associated Acute Respiratory Infections During Pregnancy
Sébastien Kenmoe, Helen Y. Chu, Fatimah S. Dawood, et al.
The Journal of Infectious Diseases (2023) Vol. 229, Iss. Supplement_1, pp. S51-S60
Open Access | Times Cited: 10
Single-Center Experience in Detecting Influenza Virus, RSV and SARS-CoV-2 at the Emergency Department
Manfred Nairz, Theodora Todorovic, Clemens M. Gehrer, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 470-470
Open Access | Times Cited: 8
Vaccination for Respiratory Syncytial Virus: A Narrative Review and Primer for Clinicians
Kay Choong See
Vaccines (2023) Vol. 11, Iss. 12, pp. 1809-1809
Open Access | Times Cited: 8
Design and Preclinical Evaluation of a Nanoparticle Vaccine against Respiratory Syncytial Virus Based on the Attachment Protein G
Richard Voorzaat, Freek Cox, Daan van Overveld, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 294-294
Open Access | Times Cited: 2
What ‘case definition’ for respiratory syncytial virus infection? Results of a systematic literature review to improve surveillance among the adults
Emanuele Amodio, Miriam Belluzzo, Dario Genovese, et al.
Journal of Public Health (2024) Vol. 46, Iss. 3, pp. 326-334
Closed Access | Times Cited: 2
Proof of stability of an RSV Controlled Human Infection Model challenge agent
Sandra Verstraelen, Dirk Roymans, An Jacobs, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Comparison of the Burden and Temporal Pattern of Hospitalisations Associated With Respiratory Syncytial Virus (RSV) Before and After COVID‐19 in New Zealand
Nikki Turner, Nayyereh Aminisani, Q. Sue Huang, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 7
Open Access | Times Cited: 2
Estimated Incidence of Hospitalizations Attributable to RSV Infection Among Adults in Ontario, Canada, Between 2013 and 2019
Marianna Mitratza, Malak Elsobky, Caihua Liang, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 9, pp. 1949-1962
Open Access | Times Cited: 2
Adult Respiratory Syncytial Virus Infection: Defining Incidence, Risk Factors for Hospitalization and Poor Outcomes, A Regional Cohort Study, 2016-2022
Tal Brosh‐Nissimov, Daniel Ostrovsky, Amos Cahan, et al.
(2024)
Open Access | Times Cited: 2
The Flavonoid Cyanidin Shows Immunomodulatory and Broad-Spectrum Antiviral Properties, Including SARS-CoV-2
Josefina Vicente, Martina Benedetti, Paula Martelliti, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 989-989
Open Access | Times Cited: 6
Comparative analysis of clinical features of lower respiratory tract infection with respiratory syncytial virus and influenza virus in adults: a retrospective study
Jia-Hua Tian, Congyue Liu, Xunling Wang, et al.
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Development of a Melting-Curve-Based Multiplex Real-Time PCR Assay for the Simultaneous Detection of Viruses Causing Respiratory Infection
Eliandro Reis Tavares, Thiago Ferreira de Lima, Guilherme Bartolomeu-Gonçalves, et al.
Microorganisms (2023) Vol. 11, Iss. 11, pp. 2692-2692
Open Access | Times Cited: 4
World Pneumonia Day 2023: the rising global threat of pneumonia and what we must do about it
Catia Cillóniz, Charles S. Dela Cruz, Walter H. Curioso, et al.
European Respiratory Journal (2023) Vol. 62, Iss. 5, pp. 2301672-2301672
Closed Access | Times Cited: 4
Epidemiology of Bronchiolitis and Respiratory Syncytial Virus and Analysis of Length of Stay from 2015 to 2022: Retrospective Observational Study of Hospital Discharge Records from an Italian Southern Province before and during the COVID-19 Pandemic
Fabrizio Cedrone, Vincenzo Montagna, Livio Del Duca, et al.
Diseases (2024) Vol. 12, Iss. 1, pp. 17-17
Open Access | Times Cited: 1
A FokI-driven signal amplification platform for the simultaneous detection of multiple viral RNA pathogens
Juan Ramón Tejedor, Annalisa Roberti, Cristina Mangas, et al.
Sensors & Diagnostics (2024) Vol. 3, Iss. 3, pp. 468-478
Open Access | Times Cited: 1
So we now have RSV vaccines. What’s our next steps?
Joseph M. Blondeau
Expert Review of Respiratory Medicine (2024) Vol. 18, Iss. 1-2, pp. 17-22
Open Access | Times Cited: 1
Respiratory syncytial virus vaccination strategies for older Canadian adults: a cost-utility analysis
Ashleigh R. Tuite, Alison E. Simmons, Monica Rudd, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Helminth induced monocytosis conveys protection from respiratory syncytial virus infection in mice
Matthew Burgess, Piotr P. Janas, Karla Berry, et al.
Allergy (2024) Vol. 79, Iss. 8, pp. 2157-2172
Open Access | Times Cited: 1
Adult Respiratory Syncytial Virus Infection: Defining Incidence, Risk Factors for Hospitalization, and Poor Outcomes, a Regional Cohort Study, 2016–2022
Tal Brosh‐Nissimov, Daniel Ostrovsky, Amos Cahan, et al.
Pathogens (2024) Vol. 13, Iss. 9, pp. 750-750
Open Access | Times Cited: 1
Immunogenicity and safety of different dose levels of Ad26.RSV.preF/RSV preF protein vaccine in adults aged 60 years and older: A randomized, double-blind, placebo-controlled, phase 2a study
Roy van Heesbeen, Arangassery Rosemary Bastian, Edmund Omoruyi, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126273-126273
Open Access | Times Cited: 1
A Model-Based Estimation of RSV-Attributable Incidence of Hospitalizations and Deaths in Italy Between 2015 and 2019
Estelle Méroc, Caihua Liang, Raffaella Iantomasi, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 11, pp. 2319-2332
Open Access | Times Cited: 1

Scroll to top